Type B aortic dissection after the use of tadalafil.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22269733.
- Also identified by DOI 10.1016/j.athoracsur.2011.07.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 63-year-old male patient with a type B aortic dissection after the use of tadalafil, a phosphodiesterase type 5 inhibitor, is presented. The possible role of a novel predisposing factor--sexual activity combined with tadalafil--is reviewed. This report and three other cases add a new dimension to the known predisposing factors such as chronic systemic hypertension, hereditary connective tissue diseases- and congenital aortic valve diseases. However, the precise role of phosphodiesterase type 5 inhibitors in the pathophysiology of aortic dissection remains unknown.
Medical subject headings
- Aortic Dissection
- Aorta, Thoracic
- Aortic Aneurysm, Thoracic
- Aortic Rupture
- Carbolines
- Phosphodiesterase 5 Inhibitors